Angiotensin II Type 1 Receptor Antagonist, Losartan, Causes Regression of Left Ventricular Hypertrophy in End-Stage Renal Disease

Publisher： Karger

E-ISSN： 2235-3186|90|3|256-261

ISSN： 1660-8151

Source： Nephron, Vol.90, Iss.3, 2002-02, pp. : 256-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II Type 1 Receptor Gene Polymorphism in End-Stage Renal Disease

By  

Nephron, Vol. 92, Iss. 1, 2002-08 ,pp. : 51-55

Karger

Access to resources Recommend Favorite

Effects of Angiotensin II and the AT1 Receptor Antagonist Losartan on the Renal Excretion of Urodilatin

By  

Kidney and Blood Pressure Research, Vol. 24, Iss. 2, 2001-06 ,pp. : 79-83

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitors but Not Angiotensin II AT 1 Receptor Antagonists Affect Erythropoiesis in Patients with Anemia of End-Stage Renal Disease

By  

Nephron, Vol. 81, Iss. 1, 1999-01 ,pp. : 106-108

Karger

Access to resources Recommend Favorite

Eccentric Left Ventricular Hypertrophy and Sudden Death in Patients with End-Stage Kidney Disease

By  

American Journal of Nephrology, Vol. 42, Iss. 2, 2015-0 ,pp. : 126-133

Karger

Access to resources Recommend Favorite

Left Atrial Dysfunction in End-Stage Renal Disease Patients Treated by Hemodialysis

By  

Nephron, Vol. 133, Iss. 3, 2016-06 ,pp. : 169-174

Karger

Access to resources Recommend Favorite